deltatrials
Unknown PHASE4 NCT00937092

Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial

Comparison of High-dose Furosemide Versus the Combination of Low-dose Furosemide and Low-dose Dopamine in Patients With Acute Decompensated Heart Failure

Sponsor: Larissa University Hospital

Conditions Acute Heart Failure
Interventions Furosemide low-dose dopamine + low-dose furosemide
Updated 5 times since 2017 Last updated: May 25, 2010 Started: Jan 31, 2009 Primary completion: Jan 31, 2010 Completion: Jul 31, 2012

This PHASE4 trial investigates Acute Heart Failure and is currently ongoing. Larissa University Hospital leads this study, which shows 5 recorded versions since 2009 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE4

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE4

  5. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE4

    First recorded

Jan 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Larissa University Hospital
Data source: Larissa University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Larissa, Greece
  • • Volos, Greece